MENU
+Compare
SPRO
Stock ticker: NASDAQ
AS OF
Jun 30, 10:46 AM (EDT)
Price
$2.95
Change
+$0.01 (+0.34%)
Capitalization
164.38M

SPRO Spero Therapeutics Forecast, Technical & Fundamental Analysis

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm... Show more

SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SPRO with price predictions
Jun 27, 2025

SPRO in upward trend: 10-day moving average broke above 50-day moving average on May 28, 2025

The 10-day moving average for SPRO crossed bullishly above the 50-day moving average on May 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

SPRO moved above its 50-day moving average on May 28, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for SPRO moved above the 200-day moving average on June 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SPRO advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 119 cases where SPRO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 42 cases where SPRO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SPRO turned negative on June 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

SPRO broke above its upper Bollinger Band on May 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SPRO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.861) is normal, around the industry mean (16.366). P/E Ratio (10.751) is within average values for comparable stocks, (58.189). SPRO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (5.663) is also within normal values, averaging (252.247).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SPRO is expected to report earnings to rise 128.00% to -56 cents per share on August 07

Spero Therapeutics SPRO Stock Earnings Reports
Q2'25
Est.
$-0.57
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.18
Q2'24
Beat
by $0.05
The last earnings report on May 13 showed earnings per share of -25 cents, beating the estimate of -27 cents. With 63.97K shares outstanding, the current market capitalization sits at 164.38M.
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKEAY1.630.11
+7.24%
Bank of East Asia Limited
PUBGY27.690.43
+1.60%
Publicis Groupe S.A.
GOCOF0.04N/A
N/A
Go Metals Corp.
IRCDF1.37N/A
N/A
Intercede Group PLC
AUSDF0.90-0.27
-23.32%
Perenti Global Ltd.

SPRO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRO has been loosely correlated with ASBP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRO jumps, then ASBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRO
1D Price
Change %
SPRO100%
+1.38%
ASBP - SPRO
62%
Loosely correlated
-7.03%
CLGN - SPRO
43%
Loosely correlated
+0.36%
ITOS - SPRO
35%
Loosely correlated
-0.60%
XENE - SPRO
32%
Poorly correlated
+0.62%
SYRE - SPRO
31%
Poorly correlated
-4.99%
More